Adam T Hill
Overview
Explore the profile of Adam T Hill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
122
Citations
3780
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alfahl Z, Einarsson G, Elborn J, Gilpin D, ONeill K, Ferguson K, et al.
Respir Med
. 2024 Dec;
236():107906.
PMID: 39643125
Background And Objective: This study explored the relationship between total bacterial density, airway microbiota composition and clinical parameters in bronchiectasis. We determined changes with time during clinical stability and following...
2.
Pollock J, Pollock J, Goeminne P, Goeminne P, Aliberti S, Aliberti S, et al.
Chest
. 2024 Oct;
PMID: 39461553
Background: Aspergillus species cause diverse clinical manifestations in bronchiectasis including allergic bronchopulmonary aspergillosis (ABPA), Aspergillus sensitization (AS), and raised IgG indicating exposure to, or infection with, Aspergillus. Research Question: What...
3.
Spinou A, Hererro-Cortina B, Aliberti S, Goeminne P, Polverino E, Dimakou K, et al.
Eur Respir J
. 2024 Apr;
63(6).
PMID: 38609097
Background: International guidelines recommend airway clearance management as one of the important pillars of bronchiectasis treatment. However, the extent to which airway clearance is used for people with bronchiectasis in...
4.
Aliberti S, Ringshausen F, Dhar R, Haworth C, Loebinger M, Dimakou K, et al.
Eur Respir J
. 2024 Apr;
63(4).
PMID: 38609095
Background: A validated 4-point sputum colour chart can be used to objectively evaluate the levels of airway inflammation in bronchiectasis patients. In the European Bronchiectasis Registry (EMBARC), we tested whether...
5.
Polverino E, Dimakou K, Traversi L, Bossios A, Haworth C, Loebinger M, et al.
J Allergy Clin Immunol
. 2024 Feb;
153(6):1553-1562.
PMID: 38401857
Background: Asthma is commonly reported in patients with a diagnosis of bronchiectasis. Objective: The aim of this study was to evaluate whether patients with bronchiectasis and asthma (BE+A) had a...
6.
Lansbury L, Lawrence H, McKeever T, French N, Aston S, Hill A, et al.
Lancet Reg Health Eur
. 2024 Jan;
37:100812.
PMID: 38170136
Background: Higher-valency pneumococcal vaccines are anticipated. We aimed to describe serotype distribution and risk factors for vaccine-serotype community-acquired pneumonia (CAP) in the two years pre-SARS-CoV-2 pandemic. Methods: We conducted a...
7.
Chang A, Boyd J, Bush A, Hill A, Powell Z, Zacharasiewicz A, et al.
Lancet Respir Med
. 2023 Dec;
12(1):78-88.
PMID: 38070531
Improving the treatment of non-cystic fibrosis bronchiectasis in children and adolescents requires high-quality research with outcomes that meet study objectives and are meaningful for patients and their parents and caregivers....
8.
Morton M, Wilson N, Homer T, Simms L, Steel A, Maier R, et al.
BMJ Open
. 2023 Aug;
13(8):e071906.
PMID: 37562935
Introduction: Bronchiectasis is a long-term lung condition, with dilated bronchi, chronic inflammation, chronic infection and acute exacerbations. Recurrent exacerbations are associated with poorer clinical outcomes such as increased severity of...
9.
Mazulov O, Hill A, Marchant J
Lancet Respir Med
. 2023 Aug;
11(8):669-670.
PMID: 37532394
No abstract available.
10.
Chalmers J, Polverino E, Crichton M, Ringshausen F, Soyza A, Vendrell M, et al.
Lancet Respir Med
. 2023 Apr;
11(7):637-649.
PMID: 37105206
Background: Bronchiectasis is a heterogeneous, neglected disease with few multicentre studies exploring the causes, severity, microbiology, and treatment of the disease across Europe. This aim of this study was to...